Henry Michael, PhD

PhD Candidate
University of KwaZulu-Natal, South Africa

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-217) Neurocognitive Effects of Transitioning to Dolutegravir-based Antiretroviral Therapy in People with HIV in sub-Saharan Africa
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET